This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
UnitedHealth Group (UNH) Laps the Stock Market: Here's Why
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $303.96, moving +1.17% from the previous trading session.
Not Just Medicare, UnitedHealth's Optum Rx Gets Its Own DOJ Checkup
by Kaibalya Pravo Dey
UNH faces a widened DOJ probe, covering Optum Rx and physician payments, as rising medical costs pressure its business.
UnitedHealth's Misdiagnosis: Can Berkshire's Bet Spark a Recovery?
by Kaibalya Pravo Dey
Berkshire's $1.57B bet on UNH sparks investor interest, but soaring costs, weak earnings and legal woes still cloud recovery hopes.
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?
by Moumi Mondal
CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.
Centene Faces HBR Pressures: Will Scale Support Stability?
by Tanuka De
CNC's rising HBR, driven by higher medical costs and policy shifts, pressures margins as it leans on scale and efficiency for stability.
UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?
by Zacks Equity Research
UNH expands behavioral health with Optum's digital tools, partnerships and integrated care to tap rising demand.
Can Elevance Health's Value-Based Care Strategy Fuel Long-Term Growth?
by Zacks Equity Research
ELV's focus on value-based care, Carelon integration and CareBridge acquisition drives membership and revenue growth.
UnitedHealth's Expansion Into ASCs: Redefining the Operating Room
by Zacks Equity Research
UNH is expanding its Optum surgery centers, cutting costs while boosting growth and patient access in value-based care.
The Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk
by Zacks Equity Research
Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.
UNH or ELV: Which Healthcare Titan Will Regain Investor Trust First?
by Kaibalya Pravo Dey
UnitedHealth and Elevance battle rising costs, but scale, Optum, and Buffett's backing give UNH the edge in restoring investor trust.
Is This the Right Time to Consider Healthcare ETFs?
by Sweta Killa
XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.
Value Outshines Growth: 5 ETF Winners Over the Past Week
by Sweta Killa
Value ETFs witness a surge as tech falters, with SPVU, RPV, RZV, RFV and GVLU gaining on rate cut bets and rotation into defensive sectors.
UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Time to Buy UnitedHealth-Heavy ETFs?
by Sanghamitra Saha
Berkshire's $1.57B stake in UnitedHealth lifted shares by 12%, sparking interest in UNH-heavy healthcare ETFs like IHF, TMED, XLV and MEDI.
UnitedHealth's Push Into Home Health: A New Growth Chapter?
by Zacks Equity Research
UNH is expanding further into home health with Optum, fueled by a $3.3B Amedisys deal to boost value-based care growth.
Buy, Hold, or Fade the Recent Rally in UnitedHealth Group (UNH) Stock?
by Shaun Pruitt
UnitedHealth Group (UNH) stock is still down 40% YTD but has surged more than +20% this month following reports that Warren Buffett, and other billionaire hedge fund managers have taken a stake in the company.
Retail Earnings Season to Commence
by Zacks Equity Research
Retail Earnings Season to Commence.
Dow Jones ETF (DIA) Hits New 52-Week High
by Sweta Killa
DIA hits a 52-week high, fueled by Dow's record and a surge in UnitedHealth after Berkshire's major stake disclosure.
Retailers Start to Report Earnings This Week
by Mark Vickery
It's the final leg of earnings season, in a general sense, to hear from the retailers who tend to stagger their earnings quarters.
Buffett's Shot in the Arm Sends UnitedHealth Soaring Against the Odds
by Kaibalya Pravo Dey
Buffett's $1.57B bet on UNH sparks a 12% surge, lifting peers despite sector headwinds and recent struggles at the insurer.
Company News for Aug 18, 2025
by Zacks Equity Research
Companies in The News Are: AMAT, UNH, BRK.A, WFC, LLY
Invest Like Warren Buffett With These ETFs
by Sanghamitra Saha
Buffett's Berkshire reshapes its portfolio with big bets on UnitedHealth and housing, while trimming Apple and Bank of America. The big bets put focus on ETFs like IHF and ITB.
Best-Performing Leveraged ETFs of Last Week
by Sanghamitra Saha
Leveraged ETFs tied to Intel, UNH, Reddit, cannabis and SoundHound soared last week as Wall Street logged broad gains despite Friday's slump. Top leveraged ETF gainers were INTW and UNHG.
Humana, DrFirst Ties Up to Boost Statin Use in High-Risk Patients
by Zacks Equity Research
HUM partners with DrFirst to increase statin use in high-risk patients with diabetes and cardiovascular disease, aiming to close care gaps.
Cardinal Health to Acquire Solaris Health for Urology Expansion
by Zacks Equity Research
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.